NOXA Expression Drives Synthetic Lethality to RUNX1 Inhibition in Pancreatic Cancer

By
Justin.choi
-
0
86
By genetic gain and loss of function experiments, scientists validated that mode of action dependWS on RUNX1 and NOXA.
[Proceedings of the National Academy of Sciences of the United States of America]
Abstract